Navigation Links
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Date:11/24/2008

on (CRO).

NOTE: Office Blood Pressure Measurements (OBPMs) were performed by a health care professional during a patient's visit to the treatment center using a standard technique and equipment (i.e. a sphygmomanometer). OBPMs were performed in the morning and the time between intake of study-drug and measurement of OBPM was between 2 and 4 hours.

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development and pre-commercialization activities for naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents for the treatment of the signs and symptoms of osteoarthritis. Naproxcinod has completed three pivotal phase 3 studies with positive results and the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) is projected for mid-2009.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension, widespread eye diseases and Chronic Obstructive Pulmonary Disease (COPD).

NicOx S.A. is headquartered in France and is listed on the NYSE Euronext Paris (Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statemen
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

13611

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
(Date:6/30/2015)... ... 30, 2015 , ... In the latest testosterone lawsuit ... are linked to testosterone replacement therapy announce an upcoming Case Management Conference to ... 9, 2015, according to court documents.* The testosterone lawsuit multidistrict litigation now includes ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Congressmen Joe Kennedy III (D-MA) and Danny Davis (D-IL) for writing to the ... its investigation into the nation’s largest behavioral healthcare system, Universal Health Services (UHS).[1] ...
(Date:6/30/2015)... ... 2015 , ... India Network Foundation today announced a new PPO ... insurance plans that provides coverage for visitors to the United States. The First ... obtain services from most experienced health care professional close to their location. , One ...
(Date:6/30/2015)... Chandler, AZ (PRWEB) , ... June 30, 2015 ... ... (League) announces that Ellen D. Wagner, Chief Research and Strategy Officer at Predictive ... Undergraduate Education at the National Science Foundation (NSF), will provide keynote addresses at ...
(Date:6/30/2015)... ... 30, 2015 , ... Under Armour’s new baselayer for football ... any other padding in football. , Developed in partnership with D3O®, a leading ... is engineered with D3O protective polymer. This radical polymer material has a unique ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2
... ... valuable information regarding the signs and symptoms of chiropractic stroke and the causes of ... ... has represented people severely injured by chiropractic neck manipulations, has launched a new website ...
... ... , ... (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by ... leading clinical trials facility in Garden City, NY, now offers opportunities for all phases ...
... ... Vice President Brian Albury will present a no-holds-barred look at Costa Rica and other countries ... America for purchasing real estate? , ... (PRWEB) May 7, 2010 -- While Costa Rica has long been the investment darling ...
... ... by the Southern Illinois University Edwardsville School of Pharmacy, today released its 40-page list ... release at the 29th Annual Scientific Meeting of the American Pain Society in Baltimore. ... Edwardsville, ...
... A Scientology ... says government and private sector cooperation against drug trafficking and drug abuse is essential and ... ... coalition of anti-drug activists Tuesday night at the new Church of Scientology of Los Angeles ...
... ... at Lipscomb University and McGavock High School over the weekend when the Cumberland River ... evacuate homes and hotels. , ... Nashville (Vocus) May 6, 2010 -- The Church of Scientology & Celebrity ...
Cached Medicine News:Health News:Chiropractic Stroke Website Launched To Aid Victims of Chiropractor Malpractice 2Health News:Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 3Health News:SIUE Pain Summit Recommendations Announced Today 2Health News:SIUE Pain Summit Recommendations Announced Today 3Health News:Scientology Official Calls for Government-Community Cooperation to Attack Drug Abuse 2Health News:Church of Scientology Nashville Mobilizes Scientology Volunteer Ministers to Cope with Floods 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: